DaVita HealthCare Partners Inc (DVA)vsNutex Health Inc (NUTX)
DVA
DaVita HealthCare Partners Inc
$192.16
-0.01%
HEALTHCARE · Cap: $13.39B
NUTX
Nutex Health Inc
$135.10
+1.71%
HEALTHCARE · Cap: $927.61M
Smart Verdict
WallStSmart Research — data-driven comparison
DaVita HealthCare Partners Inc generates 1472% more annual revenue ($13.84B vs $879.95M). NUTX leads profitability with a 11.0% profit margin vs 5.7%. NUTX trades at a lower P/E of 9.9x. DVA earns a higher WallStSmart Score of 70/100 (B-).
DVA
Strong Buy70
out of 100
Grade: B-
NUTX
Buy64
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-17.0%
Fair Value
$123.34
Current Price
$192.16
$68.82 premium
Margin of Safety
+63.6%
Fair Value
$283.22
Current Price
$135.10
$148.12 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 81 in profit
Conservative balance sheet, low leverage
Growing faster than its price suggests
Earnings expanding 43.5% YoY
Attractively priced relative to earnings
Strong operational efficiency at 37.5%
Earnings expanding 95.9% YoY
Every $100 of equity generates 28 in profit
Reasonable price relative to book value
Areas to Watch
5.7% margin — thin
Weak financial health signals
Distress zone — elevated risk
2.2% revenue growth
Smaller company, higher risk/reward
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : DVA
The strongest argument for DVA centers on Return on Equity, Debt/Equity, PEG Ratio. PEG of 0.65 suggests the stock is reasonably priced for its growth.
Bull Case : NUTX
The strongest argument for NUTX centers on P/E Ratio, Operating Margin, EPS Growth.
Bear Case : DVA
The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.
Bear Case : NUTX
The primary concerns for NUTX are Revenue Growth, Market Cap, Debt/Equity.
Key Dynamics to Monitor
NUTX carries more volatility with a beta of 2.06 — expect wider price swings.
DVA is growing revenue faster at 6.0% — sustainability is the question.
DVA generates stronger free cash flow (219M), providing more financial flexibility.
Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
DVA scores higher overall (70/100 vs 64/100). NUTX offers better value entry with a 63.6% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DaVita HealthCare Partners Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.
Nutex Health Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Nutex Health, Inc. is a technology-based healthcare services company. The company is headquartered in Houston, Texas.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?